Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer (Q28212376)
Jump to navigation
Jump to search
scientific article (publication date: 2002)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer |
scientific article (publication date: 2002) |
Statements
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancer (English)
0 references
January 2002
0 references
38
0 references
1
0 references
70-4
0 references